Evaluation of Unfavorable Cardiovascular and Metabolic Risk Factors in Children and Young Adults with Haemophilia

Autor: Yıldız M; İstanbul University Cerrahpaşa Faculty of Medicine, Department of Pediatrics, İstanbul, Turkey, Özdemir N; İstanbul University Cerrahpaşa Faculty of Medicine and Oncology Institute, Department of Pediatric Hematology and Oncology, İstanbul, Turkey, Önal H; İstanbul University Cerrahpaşa Faculty of Medicine, Department of Pediatric Metabolism and Nutrition, İstanbul, Turkey, Koç B; İstanbul University Cerrahpaşa Faculty of Medicine, Department of Pediatrics, İstanbul, Turkey, Eliuz Tipici B; İstanbul University İstanbul Faculty of Medicine, Department of Nutrition and Dietetics, İstanbul, Turkey, Zülfikar B; İstanbul University Cerrahpaşa Faculty of Medicine and Oncology Institute, Department of Pediatric Hematology and Oncology, İstanbul, Turkey
Jazyk: angličtina
Zdroj: Journal of clinical research in pediatric endocrinology [J Clin Res Pediatr Endocrinol] 2019 May 28; Vol. 11 (2), pp. 173-180. Date of Electronic Publication: 2018 Dec 24.
DOI: 10.4274/jcrpe.galenos.2018.2018.0292
Abstrakt: Objective: Increased risk of unfavorable cardiovascular risk factors has been recognised in ageing patients with haemophilia (PwH), but needs further studies in younger patients. The purpose of this study was to assess obesity, hypertension (HT), metabolic variables, insulin resistance and metabolic syndrome in young PwH.
Methods: Forty-eight haemophilia A and B patients and 35 age and sex matched healthy controls were included in the study. Anthropometric measurements, blood pressure (BP), fasting glucose and insulin levels, serum lipids and diet were evaluated. The metabolic syndrome was defined according to the criteria of the International Diabetes Federation for pediatric and adult age groups.
Results: The mean age of PwH was 21±9 years (range, 6-40 years). Of those ≥18 years, 46% were were obese/overweight while there were no obese/overweight cases in the <18 year-old patients. Obesity was more prevalent in PwH with arthropathy (p=0.017). Seven percent of the PwH between 10 and 18 years-old and 25% of those ≥18 years had metabolic syndrome. There was no difference in metabolic syndrome frequency between PwH and controls >10 years-old (19.5% vs 10% respectively, p=0.34). Fifty percent of the PwH ≥18 years-old had elevated BP or HT. Fasting blood glucose levels of PwH were significantly higher compared to controls (p=0.02).
Conclusion: Our study showed that obesity, HT and metabolic syndrome are frequent problems, especially in PwH with arthropathy. Early prevention and management of overweight, obesity and their sequelae must be addressed in clinical practice in order to maximize the overall health of the haemophilia population.
Databáze: MEDLINE
Externí odkaz: